AbbVie confirms its intention to reconsider recommendation of $54B deal to purchase Shire (SHP.UK); -2.1% afterhours; ADRs of SHPG -8.0%
AbbVie confirms its intention to reconsider recommendation of $54B deal to purchase Shire (SHP.UK); -2.1% afterhours; ADRs of SHPG -8.0%